PRA icon

ProAssurance

23.82 USD
+0.03
0.13%
At close Updated Sep 18, 1:59 PM EDT
1 day
0.13%
5 days
0.08%
1 month
-0.46%
3 months
3.93%
6 months
51.33%
Year to date
51.62%
1 year
80.05%
5 years
61.6%
10 years
-51.77%
 

About: ProAssurance Corp is a holding company for property and casualty insurance companies. The company's wholly-owned insurance subsidiaries provide professional liability insurance for healthcare professionals and facilities, professional liability insurance for attorneys, and workers' compensation insurance. ProAssurance reports operating results in five segments: Specialty Property and Casualty, Workers' Compensation, Segregated Portfolio Cell Reinsurance, Lloyd's Syndicate, and Corporate. ProAssurance generates the vast majority of its revenue from its Specialty P&C activities, followed by Worker's Compensation.

Employees: 1,036

0
Funds holding %
of 7,463 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

107% more call options, than puts

Call options by funds: $6.94M | Put options by funds: $3.36M

100% more funds holding in top 10

Funds holding in top 10: 1 [Q1] → 2 (+1) [Q2]

17% more repeat investments, than reductions

Existing positions increased: 75 | Existing positions reduced: 64

7.24% more ownership

Funds ownership: 82.76% [Q1] → 90.0% (+7.24%) [Q2]

5% more capital invested

Capital invested by funds: $1B [Q1] → $1.05B (+$48.5M) [Q2]

2% less funds holding

Funds holding: 201 [Q1] → 196 (-5) [Q2]

12% less first-time investments, than exits

New positions opened: 29 | Existing positions closed: 33

Financial journalist opinion

Positive
Zacks Investment Research
1 month ago
ProAssurance Q2 Earnings Beat Estimates on Declining Expenses
PRA's Q2 earnings top estimates as lower expenses and higher investment income offset weaker premiums.
ProAssurance Q2 Earnings Beat Estimates on Declining Expenses
Positive
Zacks Investment Research
1 month ago
ProAssurance (PRA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for ProAssurance (PRA) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
ProAssurance (PRA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Positive
Zacks Investment Research
1 month ago
ProAssurance (PRA) Surpasses Q2 Earnings and Revenue Estimates
ProAssurance (PRA) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.23 per share a year ago.
ProAssurance (PRA) Surpasses Q2 Earnings and Revenue Estimates
Neutral
Business Wire
1 month ago
ProAssurance Reports Results for Second Quarter 2025
BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported net income of $21.9 million, or $0.42 per diluted share, and operating income(1) of $26.8 million, or $0.52 per diluted share, for the three months ended June 30, 2025. For the six months ended June 30, 2025, net income was $16.1 million, or $0.31 per diluted share, and operating income was $33.6 million, or $0.
ProAssurance Reports Results for Second Quarter 2025
Neutral
Business Wire
2 months ago
The Doctors Company and ProAssurance Announce Early Termination of the Hart-Scott-Rodino Waiting Period
NAPA, Calif. & BIRMINGHAM, Ala.--(BUSINESS WIRE)--The Doctors Company, the nation's largest physician-owned medical malpractice insurer, and ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical liability, products liability for medical technology and life sciences, and workers' compensation insurance, announced today that on July 2, 2025, the U.S. Federal Trade Commission granted early termination of the waiting period under the Hart-Sc.
The Doctors Company and ProAssurance Announce Early Termination of the Hart-Scott-Rodino Waiting Period
Neutral
Business Wire
2 months ago
ProAssurance Stockholders Approve Its Proposed Acquisition by The Doctors Company
BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE: PRA) today announced that stockholders have voted overwhelmingly to approve its proposed acquisition by The Doctors Company. More than 99% of shares voted (including abstentions) were in favor of the proposal to approve the acquisition agreement. The transaction remains subject to the receipt of regulatory approvals and other customary closing conditions and is expected to close in the first half of 2026. Required regulatory app.
ProAssurance Stockholders Approve Its Proposed Acquisition by The Doctors Company
Positive
Zacks Investment Research
3 months ago
ProAssurance (PRA) Up 0.8% Since Last Earnings Report: Can It Continue?
ProAssurance (PRA) reported earnings 30 days ago. What's next for the stock?
ProAssurance (PRA) Up 0.8% Since Last Earnings Report: Can It Continue?
Negative
Zacks Investment Research
4 months ago
ProAssurance Q1 Earnings Miss Estimates on Declining Premiums
PRA reports continued growth in net investment income in the first quarter of 2025.
ProAssurance Q1 Earnings Miss Estimates on Declining Premiums
Negative
Zacks Investment Research
4 months ago
ProAssurance (PRA) Misses Q1 Earnings and Revenue Estimates
ProAssurance (PRA) came out with quarterly earnings of $0.13 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.08 per share a year ago.
ProAssurance (PRA) Misses Q1 Earnings and Revenue Estimates
Neutral
Business Wire
4 months ago
ProAssurance Reports Results for First Quarter 2025
BIRMINGHAM, Ala.--(BUSINESS WIRE)--ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical professional liability, today reported a net loss of $5.8 million, or $0.11 per diluted share, and operating income(1) of $6.8 million, or $0.13 per diluted share, for the three months ended March 31, 2025. Highlights(2) First-quarter performance demonstrated continued progress in our efforts to achieve premium rate levels appropriate for the challen.
ProAssurance Reports Results for First Quarter 2025
Charts implemented using Lightweight Charts™